Advanced implantology with a focus on rehabilitating severe jaw atrophies using short and ultra-short implant systems.

Dr. Lukas J. Brodocz is an experienced oral surgeon and implantologist with over eight years of clinical practice, specializing in advanced bone atrophies and facial aesthetic medicine. Based between Rome and Milan, he works as a Consultant Oral Surgeon and Aesthetic Medicine Specialist in leading private clinics. Since 2018, he has served as the first assistant to Prof. Andrea Cicconetti at Policlinico Umberto I, where he performs advanced surgical procedures including bone augmentation, implant rehabilitation of atrophic jaws, and management of complex oral pathologies. He is also the Clinical and Research Referent for Bicon Dental Implants in Europe and lectures internationally at major implantology congresses. Dr. Brodocz holds a Degree in Dentistry from Sapienza University of Rome and a University Diploma in Facial Aesthetic Medicine from UPEC Paris. His research focuses on implant design, surgical anatomy, and rehabilitation techniques for jaw atrophy, with publications in peer-reviewed journals. Fluent in Italian, German, and English, he brings a global perspective to dentistry, surgery, and aesthetic medicine. Reference: The Rome Classification: A Structured, Minimally Invasive Approach to Full-Arch Rehabilitation of Atrophic Jaws Using Short   Severely atrophic jaws often require complex grafting or extra-maxillary implants. Short implants offer a lower-morbidity alternative, but treatment selection remains heterogeneous. The Rome Classification was developed to standardize decision-making through measurable anatomical criteria. The main objective of the study was to assess long-term outcomes of full-arch rehabilitations retrospectively assigned to the eight scenarios of the Rome Classification. Sixty-five patients received 254 short or ultra-short implants and were followed for a mean of 70 months. Each case was assigned to a classification scenario based on CBCT-derived bone height and thickness. Surgical protocols were minimally invasive, with adjunctive procedures limited to trans-alveolar sinus lift or split-crest augmentation. Implant survival was 97.1 percent, prosthesis survival 98.4 percent, and prosthetic success 92.1 percent. Marginal bone levels remained stable from 1 to 5 years (1.40 ± 0.40 mm), and BOP decreased significantly. All classification scenarios showed similarly favorable performance. The Rome Classification provides a simple, reproducible, and minimally invasive pathway for full-arch rehabilitation in atrophic jaws, supporting predictable outcomes while reducing surgical morbidity.